112 related articles for article (PubMed ID: 1492066)
1. Atopic dermatitis: recent therapeutic advances.
de Prost Y
Pediatr Dermatol; 1992 Dec; 9(4):386-9. PubMed ID: 1492066
[TBL] [Abstract][Full Text] [Related]
2. Management of severe atopic dermatitis.
de Prost Y
Acta Derm Venereol Suppl (Stockh); 1992; 176():117-9. PubMed ID: 1282288
[TBL] [Abstract][Full Text] [Related]
3. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis.
Werfel T; Morita A; Grewe M; Renz H; Wahn U; Krutmann J; Kapp A
J Invest Dermatol; 1996 Dec; 107(6):871-6. PubMed ID: 8941677
[TBL] [Abstract][Full Text] [Related]
4. Systemic interferon gamma treatment in severe atopic dermatitis.
Reinhold U; Kukel S; Brzoska J; Kreysel HW
J Am Acad Dermatol; 1993 Jul; 29(1):58-63. PubMed ID: 8315079
[TBL] [Abstract][Full Text] [Related]
5. Recombinant interferon gamma therapy for atopic dermatitis.
Hanifin JM; Schneider LC; Leung DY; Ellis CN; Jaffe HS; Izu AE; Bucalo LR; Hirabayashi SE; Tofte SJ; Cantu-Gonzales G
J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):189-97. PubMed ID: 8432915
[TBL] [Abstract][Full Text] [Related]
6. Atopic dermatitis: the role of recombinant interferon-gamma therapy.
Chang TT; Stevens SR
Am J Clin Dermatol; 2002; 3(3):175-83. PubMed ID: 11978138
[TBL] [Abstract][Full Text] [Related]
7. Polydesensitisation with reducing elevated serum total IgE by IFN-gamma therapy in atopic dermatitis: IFN-gamma and polydesensitisation (PDS).
Lee JH; Noh G
Cytokine; 2013 Oct; 64(1):395-403. PubMed ID: 23786862
[TBL] [Abstract][Full Text] [Related]
8. The influence of interferon-gamma and interleukin-4 on IgE production in B lymphocytes of patients with atopic dermatitis. A possible criterion for selection of patients for interferon therapy.
Gruner S; Liebenthal C; Heusser C; Brinkmann V; Zwirner A; Reinicke C; Harnack K; Sönnichsen N; Volk HD
Acta Derm Venereol; 1991; 71(6):484-7. PubMed ID: 1685830
[TBL] [Abstract][Full Text] [Related]
9. Antigen presenting cell-independent cytokine and spontaneous in vitro IgE production in patients with atopic dermatitis: increased interferon-gamma production and lack of effects of in vivo low-dose interferon-gamma treatment.
Simon MR; Cooper KD; Norris RB; Blok B; King CL
J Allergy Clin Immunol; 1995 Jul; 96(1):84-91. PubMed ID: 7622767
[TBL] [Abstract][Full Text] [Related]
10. Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis.
Brar K; Leung DY
Expert Opin Biol Ther; 2016; 16(4):507-14. PubMed ID: 26694988
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine in atopic dermatitis. Modulation in the expression of immunologic markers in lesional skin.
van Joost T; Kozel MM; Tank B; Troost R; Prens EP
J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):922-8. PubMed ID: 1479097
[TBL] [Abstract][Full Text] [Related]
12. [Human recombinant interferon gamma in the treatment of atopic dermatitis].
Musiał J; Milewski M; Undas A; Kopiński P; Duplaga M; Szczeklik A
Pol Arch Med Wewn; 1994 Dec; 92(6):499-506. PubMed ID: 7716053
[TBL] [Abstract][Full Text] [Related]
13. Successful interferon alpha therapy in atopic dermatitis of Besnier's prurigo pattern with normal serum IgE and blood eosinophil fraction: randomized case-controlled study.
Noh G; Lee KY
Cytokine; 2001 Jan; 13(2):124-8. PubMed ID: 11145854
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseases.
Nasert S; Millner M; Herz U; Lack G; Wahn U; Gelfand EW; Renz H
Behring Inst Mitt; 1995 Jun; (96):118-30. PubMed ID: 7575347
[TBL] [Abstract][Full Text] [Related]
15. No relationship between skin-infiltrating TH2-like cells and allergen-specific IgE response in atopic dermatitis.
Virtanen T; Maggi E; Manetti R; Piccinni MP; Sampognaro S; Parronchi P; De Carli M; Zuccati G; Romognani S
J Allergy Clin Immunol; 1995 Sep; 96(3):411-20. PubMed ID: 7560644
[TBL] [Abstract][Full Text] [Related]
16. Atopic dermatitis: recent trends in pathogenesis and therapy.
Cooper KD
J Invest Dermatol; 1994 Jan; 102(1):128-37. PubMed ID: 8288906
[TBL] [Abstract][Full Text] [Related]
17. Use of interferons in atopic (IgE-mediated) diseases.
Pung YH; Vetro SW; Bellanti JA
Ann Allergy; 1993 Sep; 71(3):234-8. PubMed ID: 8372996
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha therapy in atopic dermatitis.
Torrelo A; Harto A; Sendagorta E; Czarnetzki BM; Ledo A
Acta Derm Venereol; 1992 Sep; 72(5):370-2. PubMed ID: 1361287
[TBL] [Abstract][Full Text] [Related]
19. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels.
Boguniewicz M; Jaffe HS; Izu A; Sullivan MJ; York D; Geha RS; Leung DY
Am J Med; 1990 Apr; 88(4):365-70. PubMed ID: 2109531
[TBL] [Abstract][Full Text] [Related]
20. Effects of interferon-alpha-2b on the clinical course, inflammatory skin infiltrates and peripheral blood lymphocytes in patients with severe atopic eczema.
Gruschwitz MS; Peters KP; Heese A; Stosiek N; Koch HU; Hornstein OP
Int Arch Allergy Immunol; 1993; 101(1):20-30. PubMed ID: 8499770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
